Clinical Trial Update: Seroquel in Bipolar Depression Versus SSRI [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating quetiapine (Seroquel) for bipolar depression, comparing it to an SSRI, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Bipolar Disorder, Bipolar Depression | Phase 3 | Status: COMPLETED